Voici la liste des lauréats de 1994 à aujourd'hui

 
AnnéePrix Galien Recherche Prix Galien Produit Innovateur
2016DR PHILIP F. HALLORAN OC, MD, Ph. D., FRCPC, FRSC

Harvoni (Sofosbuvir/Ledipasvir) (Gilead Sciences Canada)

2015DR JOHN KELTON, DR THEODORE WARKENTIN (Université McMaster)
afatinib (Giotrif) (Boehringer-Ingelheim Canada)
2014DR BRETT FINLAY (University of Alberta)
PIRFENIDONE (ESBRIET) (InterMune Canada (Roche))
2013 DR FRANCIS ALLAN PLUMMER (University of Manitoba)(YERVOY) IPILIMUMAB (Bristol Myers Squibb Canada)

2012

DR ROBERT E. W. HANCOCK

INCIVEK (TELAPREVIR) (Vertex Canada Ltd) 

VICTRELIS (BOCEPRIVIR) (Merck Canada Inc.)

2011

DR PIETER R. CULLIS (University of British Columbia)

PRADAX (Boehringer Ingelheim Canada)

2010

DR JULIO S. G. MONTANER (BC Center for Excellence in HIV/AIDS) 

STELARA (Janssen-Ortho)

2009DR DONALD F. WEAVER (University of Dalhousie)CHAMPIX  (Pfizer Canada inc.)
2008DR DANIEL J. DRUCKER (University of Toronto) GARDASIL (Merck Frosst Canada)
2007 DR MICHAEL HAYDEN (University of British Columbia)

2006 DR HAROLD JENNINGS (National Research Council Canada)

2005 DR LORNE BABIUK (University of Sakatchewan)  

2004 DR PAUL AMSTRONG (Faculty of medecine, University of Alberta) SPIRIVA (Boehringer Ingelheim Canada)
2003 DR MARK A. WAINBERG (Jewish General Hospital – Sir Mortimer B. Davis) GLEEVEC (Novartis Pharma Canada)
2002 DRS JULIA LEVEY et DAVID DOLPHIN (British Columbia University) and (ex aequo) DR ANTONY J. PAWSON (University of Toronto ) ENBREL (Wyeth-Ayerst Canada)
2001 DR SALIM YUSUF (Research Centre of the Hamilton Civic Hospital) VIAGRA (Pfizer)
2000 MONTELUKAST SODIUM RESEARCH TEAM SUR LE  (Merck Frosst) SINGULAIR (Merck Frosst)
1999 DR JACK HIRSH (Research Centre of the Hamilton Civic Hospital )LIPITOR (Parke-Davis Canada)
1998 DRS LORNE TYRRELL and MORRIS ROBIN (University of Edmonton Alberta) FOSAMAX (Merck Frosst Canada)
1997 DRS SERGE GAUTHIER, JUDES POIRIER et RÉMI QUIRION (McGill University and Research Centre of the Douglas Hospital ) 3TC (découvert par BioChem Pharma et développé par Glaxo Wellcome)
1996 ANTIVIRAL COMPOUNDS RESEARCH TEAM (BioChem Pharma) SABRIL (Marion Merrell Dow)
1995 DR PETER SCHILLER (IRCM) RISPERDAL (Janssen Pharmaceutical)
1994

DRS PHILIP SEEMAN, HYMAN NIZNIK et HUBERT VAN TOL (University of Toronto)

IMMITREX (Glaxo Canada)